Perseverance worth $100 million

Early-stage investors haven't lost their interest in biotechnology and health care, as evidenced by the $100 million life sciences fund just closed by Schroder Ventures.

Raising the money wasn't

Read the full 286 word article

How to gain access

Continue reading with a
two-week free trial.